ProImmune Limited Accelerates Development of Therapeutics with REVEAL(TM) B Cell Epitope Discovery System  
3/9/2009 9:56:29 AM

OXFORD, England--(BUSINESS WIRE)--ProImmune Ltd, a leader in epitope discovery and immune monitoring, has launched the REVEALâ„¢ B Cell Epitope Discovery System, a service designed to accelerate the development of biological therapies and understanding of diseases at a structural level. The REVEALâ„¢ service offers both comprehensive best consensus epitope prediction and rapid high throughput linear epitope mapping in vitro.